The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEMBL296435     (2S,3R)-3-(6-aminopurin-9- yl)nonan-2-ol

Synonyms: SureCN1742728, CHEBI:63059, AC1L3ZQL, CTK2H9986, DB07711, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of NCI60_002100


High impact information on NCI60_002100


Biological context of NCI60_002100


Anatomical context of NCI60_002100


Associations of NCI60_002100 with other chemical compounds


Gene context of NCI60_002100


Analytical, diagnostic and therapeutic context of NCI60_002100


  1. Inhibition of herpes simplex virus replication by purine deoxyribonucleosides. North, T.W. Cancer Res. (1984) [Pubmed]
  2. Changes in pial arteriolar diameter and CSF adenosine concentrations during hypoxia. Meno, J.R., Ngai, A.C., Winn, H.R. J. Cereb. Blood Flow Metab. (1993) [Pubmed]
  3. Enhanced postischemic ATP repletion by pharmacological inhibition of nucleoside washout and catabolism. Henrichs, K.J., Matsuoka, H., Schaper, W. J. Cardiovasc. Pharmacol. (1988) [Pubmed]
  4. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Vila Petroff, M.G., Egan, J.M., Wang, X., Sollott, S.J. Circ. Res. (2001) [Pubmed]
  5. Adenosine transport by a variant of C1300 murine neuroblastoma cells deficient in adenosine kinase. Green, R.D. Biochim. Biophys. Acta (1980) [Pubmed]
  6. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide. Jensen, B.O., Selheim, F., Døskeland, S.O., Gear, A.R., Holmsen, H. Blood (2004) [Pubmed]
  7. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics. Huang, M.C., Ashmun, R.A., Avery, T.L., Kuehl, M., Blakley, R.L. Cancer Res. (1986) [Pubmed]
  8. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine. Helland, S., Ueland, P.M. Cancer Res. (1982) [Pubmed]
  9. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells. Lin, A.L., Elford, H.L. J. Biol. Chem. (1980) [Pubmed]
  10. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine. Cristalli, G., Eleuteri, A., Franchetti, P., Grifantini, M., Vittori, S., Lupidi, G. J. Med. Chem. (1991) [Pubmed]
  11. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice. Lambe, C.U., Nelson, D.J. Biochem. Pharmacol. (1982) [Pubmed]
  12. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung. Haynes, J., Killilea, D.W., Peterson, P.D., Thompson, W.J. J. Pharmacol. Exp. Ther. (1996) [Pubmed]
  13. Characterization of a cultured human T-cell line with genetically altered ribonucleotide reductase activity. Model for immunodeficiency. Waddell, D., Ullman, B. J. Biol. Chem. (1983) [Pubmed]
  14. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Méry, P.F., Pavoine, C., Pecker, F., Fischmeister, R. Mol. Pharmacol. (1995) [Pubmed]
  15. Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. Ciccarelli, R., Di Iorio, P., D'Alimonte, I., Giuliani, P., Florio, T., Caciagli, F., Middlemiss, P.J., Rathbone, M.P. Glia (2000) [Pubmed]
  16. Characterization of a microtubule-stimulated adenosinetriphosphatase activity associated with microtubule gelation-contraction. Gao, B.C., Weisenberg, R.C. Biochemistry (1988) [Pubmed]
  17. Attenuation of cAMP accumulation in adult rat cardiac fibroblasts by IL-1beta and NO: role of cGMP-stimulated PDE2. Gustafsson, A.B., Brunton, L.L. Am. J. Physiol., Cell Physiol. (2002) [Pubmed]
  18. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells. Plunkett, W., Cohen, S.S. Cancer Res. (1975) [Pubmed]
  19. Guanine nucleotide depletion and toxicity in mouse T lymphoma (S-49) cells. Cohen, M.B., Maybaum, J., Sadee, W. J. Biol. Chem. (1981) [Pubmed]
  20. Renal interstitial adenosine metabolism during ischemia in dogs. Nishiyama, A., Kimura, S., He, H., Miura, K., Rahman, M., Fujisawa, Y., Fukui, T., Abe, Y. Am. J. Physiol. Renal Physiol. (2001) [Pubmed]
  21. Improved synthesis of 2'-deoxyformycin A and studies of its in vitro activity against mouse lymphoma of T-cell origin. Rosowsky, A., Solan, V.C., Gudas, L.J. J. Med. Chem. (1985) [Pubmed]
  22. Processing of adenosine receptor agonists in rat and human whole blood. Pavan, B., IJzerman, A.P. Biochem. Pharmacol. (1998) [Pubmed]
  23. Interleukin 2 responsive lymphocytes in patients with adenosine deaminase deficiency. Cowan, M.J., Smith, W., Ammann, A.J. Clin. Immunol. Immunopathol. (1989) [Pubmed]
  24. Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors. Barankiewicz, J., Danks, A.M., Abushanab, E., Makings, L., Wiemann, T., Wallis, R.A., Pragnacharyulu, P.V., Fox, A., Marangos, P.J. J. Pharmacol. Exp. Ther. (1997) [Pubmed]
  25. Conversion of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine to acyclovir as catalyzed by adenosine deaminase. Spector, T., Jones, T.E., Beacham, L.M. Biochem. Pharmacol. (1983) [Pubmed]
  26. Inhibition of lymphocyte function by 9-deazaadenosine. Zimmerman, T.P., Deeprose, R.D., Wolberg, G., Stopford, C.R., Duncan, G.S., Miller, W.H., Miller, R.L., Lim, M.I., Ren, W.Y., Klein, R.S. Biochem. Pharmacol. (1983) [Pubmed]
  27. Nucleoside trapping during reperfusion prevents ventricular dysfunction, "stunning," in absence of adenosine. Possible separation between ischemic and reperfusion injury. Abd-Elfattah, A.S., Jessen, M.E., Wechsler, A.S. J. Thorac. Cardiovasc. Surg. (1994) [Pubmed]
  28. Does endogenous or exogenous adenosine facilitate the functional recovery of the cochlea after ischemia? Tabuchi, K., Tsuji, S., Asaka, Y., Ito, Z., Hara, A., Kusakari, J. The Annals of otology, rhinology, and laryngology. (2002) [Pubmed]
WikiGenes - Universities